ECCO Essential Requirements for Quality Cancer Care: Colorectal Cancer. A critical review

Critical Reviews in Oncology/Hematology

Volumn 110, Issue , 2017, Pages 81-93

  Beets, Geerard ^a   Sebag Montefiore, David ^b   Andritsch, Elisabeth ^c   Arnold, Dirk ^d   Beishon, Marc ^e   Crul, Mirjam ^f   Dekker, Jan Willem ^g   Delgado Bolton, Roberto ^h   Fléjou, Jean François ⁱ   Grisold, Wolfgang ^j   Henning, Geoffrey ^k   Laghi, Andrea ^l   Lovey, Jozsef ^m   Negrouk, Anastassia ⁿ   Pereira, Philippe ^o   Roca, Pierre ^p   Saarto, Tiina ^q   Seufferlein, Thomas ^r   Taylor, Claire ^s   Ugolini, Giampaolo ^t   Velde, Cornelis van de ^u   Herck, Bert van ^v   Yared, Wendy ^w   Costa, Alberto ^x   Naredi, Peter ^y   more..

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d Instituto CUF de Oncologia (ICO)   (Portugal)

^e EUROPEAN SCHOOL OF ONCOLOGY   (Italy)

^f Department of Clinical Pharmacy   (Netherlands)

^g Department of Surgery   (Netherlands)

^h UNIVERSITY OF LA RIOJA   (Spain)

ⁱ HÔPITAL SAINT ANTOINE   (France)

^j LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^k EuropaColon   (United Kingdom)

^l SAPIENZA UNIVERSITY OF ROME   (Italy)

^m NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

ⁿ EORTC DATA CENTER   (Belgium)

^o UNIVERSITY OF HEIDELBERG   (Germany)

^p European CanCer Organisation (ECCO)   (Belgium)

^q HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^r UNIVERSITY OF ULM   (Germany)

^s EALING HOSPITAL NHS TRUST   (United Kingdom)

^t Ospedale per gli Infermi di Faenza   (Italy)

^u LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^v European CanCer Organisation (ECCO) Patient Advisory Committee   (Belgium)

^w Association of European Cancer Leagues (ECL)   (Belgium)

^x European School of Oncology (ESO)   (Belgium)

^y UNIVERSITY OF GOTHENBURG   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PROTOCOL; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; ENDOSCOPY; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HUMAN; INTERVENTIONAL RADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; NUTRITIONAL STATUS; PATIENT CARE; REVIEW; RISK FACTOR; SIGMOIDOSCOPY; SURVIVAL RATE; COLORECTAL NEOPLASMS; EUROPE; HEALTH CARE DELIVERY; MASS SCREENING; STANDARDS;

COLORECTAL NEOPLASMS; DELIVERY OF HEALTH CARE; EUROPE; HUMANS; MASS SCREENING; QUALITY OF HEALTH CARE; RISK FACTORS;

EID: 85010192467     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2016.12.001     Document Type: Review

References (63)

1. Levit, L., Balogh, E., Nass, S., Ganz, P., (eds.) Delivering High-quality Cancer Care: Charting a New Course for a System in Crisis, 2013, Institute of Medicine. National Academies Press, 10.17226/18359.
2. Borras, J.M., Albreht, T., Audisio, R., Briers, E., Casali, P., Esperou, H., et al. Policy statement on multidisciplinary cancer care. Eur. J. Cancer 50:3 (2014), 475–480, 10.1016/j.ejca.2013.11.012.
3. Cardoso, F., Cataliotti, L., Costa, A., Knox, S., Marotti, L., Rutgers, E., et al. European Breast Cancer Conference manifesto on breast centres/units. Eur. J. Cancer, 2016, 10.1016/j.ejca.2016.10.023.
4. Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J.W., Comber, H., et al. Cancer incidence and mortality patterns in Europe: estimated for 40 countries in 2012. Eur. J. Cancer 49:6 (2013), 1374–1403, 10.1016/j.ejca.2012.12.027.
5. Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. 2013, International Agency for Research on Cancer http://globocan.iarc.fr.
6. Holleczek, B., Rossi, S., Domenic, A., Innos, K., Minicozzi, P., Francisci, S., et al. On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999–2007–results from the EUROCARE-5 study. Eur. J. Cancer 51:15 (2015), 2158–2168, 10.1016/j.ejca.2015.07.024.
7. Jansen, L., Herrmann, A., Stegmaier, C., Singer, S., Brenner, H., Arndt, V., Health-related quality of life during the 10 years after diagnosis of colorectal cancer: a population-based study. J. Clin. Oncol. 29:24 (2011), 3263–3269, 10.1200/JCO.2010.31.4013.
8. European Commission, European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis. first edition, 2010 http://bookshop.europa.eu/is-bin/INTERSHOP.enfinity/WFS/EU-Bookshop-Site/en_GB/-/EUR/ViewPublication-Start?PublicationKey=ND3210390.
9. Healthcare Quality Improvement Partnership, National Bowel Cancer Audit Report., 2015 http://www.hqip.org.uk/resources/national-bowel-cancer-audit-report-2015.
10. Jansen, L., Koch, L., Brenner, H., Arndt, V., Quality of life among long-term (≥5 years) colorectal cancer survivors –Systematic review. Eur. J. Cancer 46:6 (2010), 2879–2888, 10.1016/j.ejca.2010.06.010.
11. Kamiński, M.F., Hassan, C., Bisschops, R., Pohl, J., Dekker, E., Ignjatovic-Wilson, A., et al. Advanced imaging for detection and differentiation of colorectal neoplasia: european Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 46:5 (2014), 435–449, 10.1055/s-0034-1365348.
12. Rees, C.J., Thomas-Gibson, S., Rutter, M.D., Baragwanath, P., Pullan, R., Feeney, M., et al. UK key performance indicators and quality assurance standards for colonoscopy. Gut 65:12 (2016), 1923–1929, 10.1136/gutjnl-2016-312044.
13. Bretthauer, M., Aabakken, L., Dekker, E., Kaminski, M.F., Rösch, T., Hultcrantz, R., et al. Reporting systems in gastrointestinal endoscopy: requirements and standards facilitating quality improvement: european Society of Gastrointestinal Endoscopy position statement. United Eur. Gastroenterol. J. 4:2 (2016), 172–176, 10.1177/2050640616629079.
14. Nagtegaal, I.D., Current concepts of colorectal cancer resection pathology. Histopathology 66:1 (2015), 102–111, 10.1111/his.12563.
15. Quirke, P., Risio, M., Lambert, R., von Karsa, L., Vieth, M., Quality assurance in pathology in colorectal cancer screening and diagnosis –European recommendations. Virchows Arch. 458:1 (2011), 1–19, 10.1007/s00428-010-0977-6.
16. Loughrey, M.B., Quirke, P., Shepherd, N.A., Dataset for Colorectal Cancer Histopathology Reports., 3rd edition, 2014, Royal College of Pathologists https://www.rcpath.org/resourceLibrary/dataset-for-colorectal-cancer-histopathology-reports-3rd-edition-.html.
17. Royal College of Pathologists of Australasia, Polypectomy and Local Resections of the Colorectum. Structured Reporting Protocol., 1st edition, 2013 www.rcpa.edu.au/getattachment/2663804e-2810-4376-98cf-d2add98e5425/Protocol-Polypectomy-local-resections-CR.aspx.
18. Beets-Tan, R.G., Lambregts, D.M., Maas, M., Bipat, S., Barbaro, B., Caseiro-Alves, F., et al. Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur. Radiol. 23:9 (2013), 2522–2531, 10.1007/s00330-013-2864-4.
19. Neri, E., Halligan, S., Hellström, M., Lefere, P., Mang, T., Regge, D., et al. The second ESGAR consensus statement on CT colonography. Eur. Radiol. 3:3 (2013), 720–729, 10.1007/s00330-012-2632-x.
20. van Kessel, C.S., Buckens, C.F., van den Bosch, M.A., van Leeuwen, Hillegersberg, R., Verkooijen Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis. Ann. Surg. Oncol. 19:9 (2012), 2805–2813, 10.1245/s10434-012-2300-z.
21. Van Leersum, N.J., Snijders Henneman, H.S.D.D., Kolfschoten, G.A., Gooiker, M.G., ten Berge, E.H., et al. The dutch surgical colorectal audit. Eur. J. Surg. Oncol. 39:10 (2013), 1063–1070, 10.1016/j.ejso.2013.05.008.
22. SONCOS (Dutch foundation for oncological collaboration), Colorectal Standards Report., 2016 (English version in progress) http://www.soncos.org.
23. National Institute for Health and Care Excellence, Colorectal Cancer: Diagnosis and Management. Clinical Guidleine 131. 2014 (updated 2014) https://www.nice.org.uk/guidance/cg131.
24. Are, C., Berman, R.S., Wyld, L., Cummings, C., Lecoq, C., Audisio, R.A., et al. Global curriculum in surgical oncology. Eur. J. Surg. Oncol. 42:6 (2016), 754–766, 10.1016/j.ejso.2016.04.005.
25. Valentini, V., Glimelius, B., Haustermans, K., Marijnen, C.A., Rödel, C., Gambacorta, M.A., et al. EURECCA consensus conference highlights about rectal cancer clinical management: the radiation oncologist's expert review. Radiother. Oncol. 110:1 (2014), 195–198, 10.1016/j.radonc.2013.10.024.
26. Glimelius, B., Tiret, E., Cervantes, A., Arnold, D., ESMO Guidelines Working Group Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 24:Suppl. 6 (2013), vi81–8.
27. Labianca, R., Nordlinger, B., Beretta, G.D., Mosconi, S., Cervantes, A., Arnold, D., et al. Early colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 24:Suppl. 6 (2013), vi64–vi72, 10.1093/annonc/mdt354.
28. Van Cutsem, Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J.H., Aderka, D., et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncology 27:8 (2016), 1386–1422, 10.1093/annonc/mdw235.
29. Gillams, A., Goldberg, N., Ahmed, M., Bale, R., Breen, D., Calistrom, M., et al. Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts. Eur. Radiol. 25:12 (2015), 3438–3454, 10.1007/s00330-015-3779-z.
30. Tanis, E., Nordlinger, B., Mauer, M., Sorbye, H., van Coevorden, F., Gruenberger, T., et al. Local recurrence rates after RFA and resection of colorectal liver metastases –a descriptive analysis of EORTC CLOCC and EPOC databases. Eur. J. Cancer, 38(9), 2012, 795, 10.1016/j.ejso.2012.06.186.
31. de Baère, T., Aupérin, A., Descamps, P., Chevallier, P., Gaubert, Y., Boige, V., et al. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann. Oncol. 26:5 (2015), 591–987, 10.1093/annonc/mdv037.
32. National Cancer Action Team, Excellence in Cancer Care: The Contribution of the Clinical Nurse Specialist. 2010 http://www.macmillan.org.uk/documents/aboutus/commissioners/excellenceincancercarethecontributionoftheclinicalnursespecialist.pdf.
33. Macmillan Cancer Support, Cancer Clinical Nurse Specialists: an Evidence Review. 2011 http://www.macmillan.org.uk/Documents/AboutUs/Commissioners/ClinicalNurseSpecialistsAnEvidenceReview2012.pdf.
34. Maas, M., Rutten, I.J., Nelemans, P.J., Lambregts, D.M., Cappendijk, V.C., Beets, G.L., et al. What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis: imaging for recurrent colorectal cancer. Eur. J. Nucl. Med. Mol. Imaging 38:8 (2011), 1560–1571, 10.1007/s00259-011-1785-1.
35. Maffione, A.M., Lopci, E., Bluemel, C., Giammarile, F., Hermann, K., Rubello, D., Diagnostic accuracy and impact on management of (18)F-FDG PET and PET/CT in colorectal liver metastasis: a meta-analysis and systematic review. Eur. J. Nucl. Med. Mol. Imaging 42:1 (2015), 152–163, 10.1007/s00259-014-2930-4.
36. Boellaard, R., Delgado-Bolton, R., Oyen, W.J., Giammarile, F., Tatsch, K., Eschner, W., et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur. J. Nucl. Med. Mol. Imaging 42:2 (2015), 328–354, 10.1007/s00259-014-2961-x.
37. Decoster, L., Van Puyvelde, K., Mohile, S., Wedding, U., Basso, U., Colloca, G., et al. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations. Ann. Oncol. 26:2 (2015), 288–300, 10.1093/annonc/mdu210.
38. Papamichael, R.A., Audisio, B., Glimelius, A., de Gramont, A., Glynne-Jones, R., Haller, D., et al. Treatment of colorectal cancer in older patients. International Society of Geriatric Oncology (SIOG) consensus recommendations 2013. Ann. Oncol. 26:3 (2015), 463–476, 10.1093/annonc/mdu253.
39. European Society of Oncology Pharmacy, Quality Standard for the Oncology Pharmacy Service (QuapoS 5). 2014 http://www.esop.li/activities.php.
40. Mehnert, A., Brähler, E., Faller, H., Härter, M., Keller, M., Schulz, H., et al. Four-week prevalence of mental disorders in patients with cancer across major tumour entities. J. Clin. Oncol. 32:31 (2014), 3540–3546, 10.1200/JCO.2014.56.0086.
41. El-Shami, K., Oeffinger, K.C., Erb, N.L., Willis, A., Bretsch, J.K., Pratt-Chapman, M.L., et al. American cancer society colorectal cancer survivorship care guidelines. CA Cancer J. Clin. 65:6 (2015), 428–455, 10.3322/caac.21286.
42. Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., et al. ESPEN guidelines on nutrition in cancer patients. Clin. Nutr. S0261–5614:16 (2016), 30181–30189, 10.1016/j.clnu.2016.07.015.
43. Bozzetti, F., Arends, J., Lundholm, K., Micklewright, A., Zurcher, G., Muscaritoli, M., ESPEN guidelines on parenteral nutrition: non-surgical oncology. Clin. Nutr. 28:4 (2009), 445–454, 10.1016/j.clnu.2009.04.011.
44. Temel, J.S., Greer, J.A., Muzikansky, A., Gallagher, E.R., Admane, A., Jackson, V.A., et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N. Engl. J. Med. 363:8 (2010), 733–742, 10.1056/NEJMoa1000678.
45. Quill, T.E., Abernethy, A.P., Generalist plus specialist palliative care –creating a more sustainable model. N. Engl. J. Med. 368:13 (2013), 1173–1175, 10.1056/NEJMp1215620.
46. Hui, D., Bansal, S., Strasser, F., Morita, T., Caraceni, A., Davis, M., et al. Indicators of integration of oncology and palliative care programmes: an international consensus. Ann. Oncol. 26:9 (2015), 1953–1959, 10.1093/annonc/mdv269.
47. Stubblefield, M.D., Hubbard, G., Cheville, A., Koch, U., Schmitz, K.H., Dalton, S.O., Current perspectives and emerging issues on cancer rehabilitation. Cancer 119:Suppl. 11 (2013), 2170–2178, 10.1002/cncr.28059.
48. Berg, L., Nolbris, M.J., Koinberg, I., Melin-Johansson, C., Möller, A., Ohlén, J., Characterisation of cancer support and rehabilitation programmes: a Swedish multiple case study. Open Nurs. J. 8 (2016), 1–7, 10.2174/1874434601408010001.
49. Scott, D.A., Mills, M., Black, A., Cantwell, M., Campbell, A., Cardwell, C.R., et al. Multidimensional rehabilitation programmes for adult cancer survivors. Cochrane Database Syst. Rev., 3, 2013, CD007730, 10.1002/14651858 (pub2).
50. McMullen, C.K., Bulkley, J.E., Altschuler, A., Wendel, C.S., Grant, M., Hornbrook, M.C., et al. Greatest challenges of rectal cancer survivors: results of a population-based survey. Dis. Colon Rectum 59:11 (2016), 1019–1027, 10.1097/DCR.0000000000000695.
51. Downing, A., Morris, E., Richards, M., Corner, J., Wright, P., Sebag-Montefiore, D., et al. Health-related quality of life after colorectal cancer in England: a patient-reported outcomes study of individuals 12–36 months after diagnosis. J. Clin. Oncol. 33:6 (2015), 616–624, 10.1200/JCO.2014.56.6539.
52. Mota, D.D., Pimenta, C.A., Caponero, R., Fatigue in colorectal cancer patients: prevalence and associated factors. Rev. Lat. Am. Enfermagem. 20:3 (2012), 495–503, 10.1590/S0104-11692012000300010.
53. Grisold, W., Cavaletti, G., Windebank, A.J., Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment and prevention. Neuro Oncol. 14:Suppl. 4 (2012), iv45–iv54, 10.1093/neuonc/nos203.
54. Park, S.B., Goldstein, D., Krishnan, A.V., Lin, C.S., Friedlander, M.L., Cassidy, J., et al. Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA. Cancer J. Clin. 63:6 (2013), 419–437, 10.3322/caac.21204.
55. Wind, A., Rajan, A., van Harten, W.H., Quality assessments for cancer centres in the European Union. BMC Health Serv. Res., 16, 2016, 474, 10.1186/s12913-016-1738-2.
56. Breugom, A.J., Boelens, P.G., van den Broek, C.B., Cervantes, A., Van Cutsem, E., Schmoll, H.J., et al. Quality assurance in the treatment of colorectal cancer: the EURECCA initiative. Ann. Oncol. 25:8 (2014), 1485–1492, 10.1093/annonc/mdu039.
57. van de Velde, C.J.H., Boelens, P.G., Borras, J.M., Coebergh, J.W., Cervantes, A., Blomqvist, L., et al. EURECCA colorectal: multidisciplinary management: european consensus conference colon & rectum. Eur. J. Cancer, 50(1), 2014, 1, 10.1016/j.ejca.2013.06.048 (e1-1. e34).
58. Jannasch, O., Udelnow, A., Wolff, S., Lippert, H., Mroczkowski, P., German bowel cancer centre: An attempt to improve treatment quality. Gastroenterol. Res. Pract., 2015, 456476, 10.1155/2015/456476.
59. Wesselman, A., Winter, A., Ferencz, J., Seufferlein, T., Post, S., Documented quality of care in certified colorectal cancer centres in Germany: German Cancer Society benchmarking report for 2013. Int. J. Colorectal Dis. 29:4 (2014), 511–518, 10.1007/s00384-014-1842-x.
60. Bianchi, V., Spitale, A., Ortelli, L., Mazzucchelli, L., Bordoni, A., The QC3 CRC Working Group. Quality indicators of clinical cancer care (QC3) in colorectal cancer. BMJ Open, 3, 2013, e002818, 10.1136/bmjopen-2013-002818.
61. Chawla, N., Butler, E.N., Lund, J., Warren, J.L., Harlan, L.C., Yabroff, K.R., Patterns of colorectal care in europe, Australia, and New Zealand. J. Natl. Cancer Inst. Monogr. 2013:46 (2013), 36–61, 10.1093/jncimonographs/lgt009.
62. Downing, A., Morris, E.J.A., Corrigan, N., Sebag-Montefiore, D., Finan, P.J., Thomas, J.D., et al. High hospital research participation and improved colorectal cancer survival outcomes: a population-based study. Gut, 2016, 10.1136/gutjnl-2015-311308.
63. Kaźmierska, J., Do we protect or discriminate? Representation of senior adults in clinical trials. Rep. Pract. Oncol. Radiother. 1 (2013), 6–10, 10.1016/j.rpor.2012.08.006.